Skip to content
TrialScanner

NCT06510855

DurAVR™ THV EU-EFS

No phase registeredActive, not recruitingAVRLead

Registry record

Lead sponsor
Anteris Technologies Ltd.
Conditions
Symptomatic Aortic Stenosis; Severe Aortic Valve Stenosis; Aortic Valve Calcification; Aortic Valve Failure; Aortic Valve Disease
Primary completion
Jun 11, 2026Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT06510855 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT06510855: DurAVR™ THV EU-EFS | TrialScanner